Session: Raising adherence as a public health priority - Acare HCP Global
Skip to content
Home > Congress > Session > Session: Panel discussion – Raising adherence as a public health priority

Panel discussion – Raising adherence as a public health priority

This panel discussion aimed to identify and catalyze ideas to raise awareness of adherence as a public health priority. In this panel discussion, experts share their perspectives on medication non-adherence as a public health priority taking into consideration regional challenges and particularities. The group discussed the importance of building networks through workshops and conferences, raising awareness of medication non-adherence to key stakeholders including governments and health authorities, and leveraging the right tools to help disseminate information by collaborating with medical societies and journals for instance. The experts shared out-of-the-box ideas to ensure adherence becomes a public health priority.


Speakers

PROF. JOHN
WEINMAN

United Kingdom

Prof. Enrique
De Madaria

Spain

Dr. Shashank
Joshi

India satellite

Prof. Pavel
Klein

United States of America

Prof. Marcus
Malachias

Brazil satellite

Dr. Zuluaga
Hector Medina

Latin America satellite

Prof. Badr
Eldin Moustafa

Middle East, Turkey, Africa and Pakistan satellite

Prof. Nuri
Ozgirgin

Middle East, Turkey, Africa and Pakistan satellite

Prof. Alta
Schutte

Australia

Prof. Tommaso
Simoncini

Italy

Assoc. Prof. Ngiap
Chuan Tan

Asia-Pacific satellite

Share this post

Read more on this topic

Session: Panel discussion - Sharing reflections and best practice

Session: Congress introduction second day

Session: Closing congress first day

Session: Patient perspectives of adherence and how these can help us improve…

Session: International Society of Hypertension - Raising awareness on…

Session: International Society of Gynecological Endocrinology - From treating…

Session: Closing congress

Session: Practical individual interventions any healthcare professionals can…

Session: The challenge and causes of non-adherence

Session: Consequences of non-adherence to narrow therapeutic index drugs

Session: The paradox of non-adherence to treatment in oncology

Session: Non-adherence is the new cardiovascular risk factor